Increased plasma pancreastatin-like levels in gestational diabetes: Correlation with catecholamine levels

Diabetes Care

Volumn 21, Issue 11, 1998, Pages 1951-1954

  Sánchez Margalet, Víctor ^a   Lobón, José Antonio ^b   González, Amalia ^b   Escobar Jiménez, Fernando ^b   Goberna, Raimundo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; GLUCAGON; GLUCOSE; INSULIN; NORADRENALIN; PANCREASTATIN;

ADULT; ARTICLE; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS;

BLOOD GLUCOSE; CATECHOLAMINES; DIABETES, GESTATIONAL; EPINEPHRINE; FASTING; FEMALE; HUMANS; INSULIN; NOREPINEPHRINE; PANCREATIC HORMONES; PEPTIDE FRAGMENTS; PREGNANCY; RADIOIMMUNOASSAY;

EID: 0031755626     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.11.1951     Document Type: Article

References (34)

1. Tatemoto K, Efendic S, Mutt V Makk G, Feistner GJ, Barchas JC: Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324:476-478, 1986
2. Iancangelo AL, Fischer-Colbrie R, Koller KJ, Brownstein MJ, Eiden LE: The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology 155:2339-2341, 1988
3. Iancangelo AL, Affolter HU, Eiden LE, Herbert E, Grimes M: Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature 323:82-36, 1986
4. Sánchez-Margalet Y Lucas M, Goberna R: Pancreastatin: further evidence for its consideration as a regulatory peptide, J Mol Endocrinol 16:1-8, 1996
5. Sánchez-Margalet V Lucas M, Goberna R: Pancreastatin action in the liver: dual coupling to different G proteins. Cell Signal 8:9-12, 1996
6. Sánchez V, Calvo JR, Goberna R: Glycogenolytic effect of pancreastatin in the rat. Biosd Rep 10:87-91, 1990
7. 2+-dependent mechanism. Biochem J 284:659-662, 1992
8. Sánchez-Margalet V, Goberna R: Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regul Peptides 51:215-220, 1994
9. Sánchez-Margalet V, Valle M, Gobema R: Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking. Mol Pharmacol 46:24-29, 1994
10. Sánchez-Margalet V Santos-Alvarez J: Solubilization and molecular characterization of pancreastatin receptors from rat liver membranes. Endocrinology 138:1712-1718, 1997
11. 2 + in rat hepatocytes, involving both pertussistoxin-sensitive and -insensitive mechanisms. Biochem J 294:439-442, 1993
12. Sánchez-Margalet V, Lucas M, Gobema R: Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes. Biochem J 303:51-54, 1994
13. q/11α in rat liver membranes. Hepatology 27:608-614, 1998
14. Sánchez-Margalet V, Goberna R: Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes. J Cell Biochem 55:173-181, 1994
15. Winkler H, Fischer-Colbrie R: The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49:497-528, 1992
16. Watkinson A, Johnson AC, Davison M, Young J, Lee CM, Moore S, Dockray GJ: Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochem J 276:471-479, 1991
17. Simon JP, Bader MF, Aunis D: Proteolytic processing of CGA in cultured chromaffin cells. Biochem Biophys Acta 1051:123-130, 1989
18. Watkinson A, Johnson AC, Davison M, Young J, Lee CM, Moore S, Dockray GJ: Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine gut, pancreas and adrenal medulla. Biochem J 295:649-654, 1993
19. Konecki DS, Benedum UM, Gerdes H-H, Huttner WB: The primary structure of human chromogranin A and pancreastatin. J Biol Chem 262:17026-17030, 1987
20. O'Connor DT, Deftos LJ: Secretion of chromogramin A by peptide-producing endocrine neoplasms. N Engl J Med 314:1145-1151, 1986
21. Syversen U, Mignon M, Bonfils S, Kristensen A, Waldum HL: Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol 32:161-165, 1993
22. McGrath-Linden SJ, Johnston CF, O'Connor DT, Shaw C, Buchanan KD: Pancreastatin-like immunoreactivity in human carcinoid disease. Regul Pept 33:55-70, 1991
23. Dimsdale JE, O'Connor DT, Ziegler M, Mills P: Chromogranin A correlates with norepinephrine release rate. Life Sci 51:519-525, 1992
24. Syversen U, Jacobsen MB, O'Connor DT, Ronning K, Waldum HL: Immunoassays for measurement of chromogranin A and pancreastatin-like immnunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Neuropeptides 26:201-206, 1994
25. Sánchez-Margalet V, Valle M, Lobón JA, Maldonado A, Escobar F, Oliván J, Perez-Cano R, Goberna R: Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension, J Hypertens 13:251-258, 1995
26. Sánchez-Margalet V, Valle M, Lobón JA, Escobar-Jimenez F, Perez-Cano R, Goberna R: Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides 29:97-101, 1995
27. Syversen U, Opsjøn SL, Stridsberg M, Sandvik AK, Dimaline R, Tingulstad S, Amtzen KJ, Brenna E, Waldum HL: Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies. J Gin Endocrinol Metab 81:4470-4475, 1996
28. Ryan EA, O'Sullivan MJ, Skyler JS: Insulin action during pregnancy: studies with the euglycemic clamp technique. Diabetes 34:380-389, 1985
29. Kühl C: Insulin secretion and insulin resistance in pregnancy and GDM: implications for diagnosis and management. Diabetes 40 (Suppl. 2): 18-24, 1991
30. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
31. Petraglia F, Volpe A, Genazzani AR, Rivier J, Sawchenko PE, Vale W: Neuroendocrinology of the human placenta. Front Neuroendocrinol 11:6-37, 1990
32. Schober M, Fischer-Colbrie R, Winkler H: Ontogenesis of chromogranin A and B and catecholamines in rat adrenal medulla. Brain Res 478:41-46, 1989
33. Sánchez-Margalet V Goberna R: Pancreastatin, a new peptide associated with essential hypertension and hyperinsulinemia. In Biologie Prospective. Galteau MM, Henny J, Siest G, Eds. Paris, John Libbey Eurotext, 1993, p. 575-580
34. Sánchez-Margalet Y Santos-Alvarez J, Goberna R: Pancreastatin signaling in the liver. In Neurochemistry: Cellular, Molecular and Clinical Aspects. Teelken A, Korf J, Eds, New York, Plenum, 1997, p. 589-593